ACTIVE

Eqwal Stomacare

Export PDF

Financial year 2025 · closed on 30/09/2025

Net result

233,9 k €

-15.7% YoY

Gross margin

1,4 M €

-7.8% YoY

Equity

1,2 M €

+23.7% YoY

Workforce

7,6 ETP

-1.3% YoY

What does Eqwal Stomacare do?

Eqwal Stomacare is a Private limited company incorporated in 2012. Its main activity is: Retail sale of medical and orthopaedic goods in specialised stores. Its registered office is in Gent. It employs on average 7,6 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0849.873.517

Incorporation

18/10/2012

Legal form

Private limited company

Registered office

Herman Teirlinckstraat 15
9041 Gent · FlandreSee on map

Contributed capital

20 000,00 €

Latest accounts

30/09/2025

Average workforce

7,6 ETP

Activities (NACE)

47740Retail sale of medical and orthopaedic goods in specialised stores· main 47741Retail sale of medical and orthopaedic goods in specialised stores 86220Specialist medical practice activities 86220Specialist medical practice activities

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 12 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014
Income statement
Gross margin	1,4 M €	-7.8%	1,5 M €	+35.5%	1,1 M €	+94.9%	570,1 k €	-68.9%	1,8 M €	+49.9%	1,2 M €	+60.1%	764 k €	+3.7%	737 k €	+15.2%	639,6 k €	+26.1%	507,2 k €	+32.5%	382,7 k €	-18.2%	467,9 k €
EBITDA	427,4 k €	-28.8%	600,6 k €	+176%	217,5 k €	+175%	79,2 k €	-91.0%	883,2 k €	+39.8%	631,6 k €	+192%	216,4 k €	+64.4%	131,7 k €	+16.1%	113,4 k €	-11.7%	128,4 k €	+17.3%	109,4 k €	+8.3%	101,1 k €
Operating result	290,9 k €	-23.2%	378,9 k €	+137%	160,1 k €	+485%	27,4 k €	-96.5%	774,1 k €	+39.9%	553,2 k €	+355%	121,7 k €	+111%	57,7 k €	+52.1%	37,9 k €	-31.6%	55,5 k €	+66.6%	33,3 k €	-29.1%	47 k €
Net result	233,9 k €	-15.7%	277,4 k €	+138%	116,7 k €	+758%	13,6 k €	-97.6%	571,8 k €	+52.4%	375,3 k €	+431%	70,7 k €	+242%	20,7 k €	+1042%	1,8 k €	-90.0%	18,1 k €	+202%	6 k €	-66.3%	17,9 k €
Balance sheet
Equity	1,2 M €	+23.7%	984,9 k €	-18.4%	1,2 M €	+10.7%	1,1 M €	+1.3%	1,1 M €	+113%	505,4 k €	+288%	130,1 k €	+54.1%	84,5 k €	+32.4%	63,8 k €	+2.9%	62 k €	+41.3%	43,9 k €	+15.9%	37,9 k €
Total assets	2,7 M €	+7.6%	2,5 M €	+14.9%	2,2 M €	+11.8%	1,9 M €	-17.3%	2,3 M €	+27.3%	1,8 M €	+32.8%	1,4 M €	+12.4%	1,2 M €	+3.2%	1,2 M €	-5.0%	1,3 M €	+3.0%	1,2 M €	+103%	601,2 k €
Cash	353,1 k €	-1.5%	358,4 k €	-2.5%	367,5 k €	-39.1%	603,7 k €	-12.7%	691,6 k €	+0.8%	686 k €	+113%	321,9 k €	+116%	148,9 k €	+28.0%	116,3 k €	-47.0%	219,3 k €	-21.7%	280,2 k €	+37.6%	203,6 k €
Debts	1,5 M €	-2.9%	1,5 M €	+56.9%	958,6 k €	+13.2%	847 k €	-29.7%	1,2 M €	-6.9%	1,3 M €	+3.0%	1,3 M €	+9.4%	1,1 M €	+1.6%	1,1 M €	-5.4%	1,2 M €	+1.5%	1,2 M €	+117%	543,6 k €
Other
Workforce	7,6 ETP	-1.3%	7,7 ETP	-2.5%	7,9 ETP	+19.7%	6,6 ETP	0.0%	6,6 ETP	+10.0%	6,0 ETP	0.0%	6,0 ETP	0.0%	6,0 ETP	+1.7%	5,9 ETP	+37.2%	4,3 ETP	+30.3%	3,3 ETP	0.0%	3,3 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Governance

Board of directors

Seen on filing of 30/09/2025 · 1 active · 8 ended

Active mandates

FINICOMA

Director · since 30 juin 2022 · 0668.547.457

Represented by Jean-Pierre MAHÉ

Active

Ended mandates

FINICOMA

Director · since 30 juin 2022 · 0668.547.457

Represented by Jean-Pierre MAHÉ

Ended

Hilde Persoon

Director · until 30 juin 2022

Ended

Hilde PERSOON

Director

Ended

Hilde PERSOON

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
Eqwal● Active	0426.419.720
Eqwal Care● Active	0707.608.763
Eqwal Roeselare● Active	0450.255.093
FINICOMA● Active	0668.547.457
Nixa-Phone● Liquidation	0827.622.410

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/10/2024	01/10/2023	01/10/2022	01/01/2022	01/07/2020	01/07/2019
Closing of the financial year	30/09/2025	30/09/2024	30/09/2023	30/09/2022	31/12/2021	30/06/2020
Length of the financial year	12 months	12 months	12 months	9 months	18 months	12 months
Filing date	22/04/2026	06/05/2025	25/06/2024	27/04/2023	13/07/2022	04/02/2021
General meeting	31/03/2026	30/04/2025	14/06/2024	30/03/2023	17/06/2022	18/12/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

12 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	30/09/2025	31/03/2026	22/04/2026	Dutch	PDF
Abridged model	30/09/2024	30/04/2025	06/05/2025	Dutch	PDF
Abridged model	30/09/2023	14/06/2024	25/06/2024	Dutch	PDF
Abridged model	30/09/2022	30/03/2023	27/04/2023	Dutch	PDF
Abridged model	31/12/2021	17/06/2022	13/07/2022	Dutch	PDF
Abridged model	30/06/2020	18/12/2020	04/02/2021	Dutch	PDF
Abridged model	30/06/2019	20/12/2019	15/01/2020	Dutch	PDF
Abridged model	30/06/2018	21/12/2018	31/01/2019	Dutch	PDF
Abridged model	30/06/2017	15/12/2017	27/12/2017	Dutch	PDF
Abridged model	30/06/2016	16/12/2016	06/01/2017	Dutch	PDF
Abridged model	30/06/2015	18/12/2015	28/01/2016	Dutch	PDF
Abridged model	30/06/2014	19/12/2014	16/02/2015	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/09/2025 · 1 active · 8 ended

Active mandates

FINICOMA

Director · since 30 juin 2022 · 0668.547.457

Represented by Jean-Pierre MAHÉ

Active

Ended mandates

FINICOMA

Director · since 30 juin 2022 · 0668.547.457

Represented by Jean-Pierre MAHÉ

Ended

Hilde Persoon

Director · until 30 juin 2022

Ended

Hilde PERSOON

Director

Ended

Hilde PERSOON

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Registered office17/10/2025
MAATSCHAPPELIJKE ZETEL
PDF
Other13/10/2025
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - BENAMING
PDF
Mandates26/06/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates11/06/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates28/11/2022
ONTSLAGEN - BENOEMINGEN
PDF
Other31/08/2022
ALGEMENE VERGADERING - BOEKJAAR
PDF
Mandates17/08/2022
ONTSLAGEN - BENOEMINGEN
PDF
Other30/06/2021
ALGEMENE VERGADERING - BOEKJAAR
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025233,9 k €↓
2025
Name changeEqwal Stomacare
2024
Annual accounts 2024277,4 k €↑
2023
Annual accounts 2023116,7 k €↑
2022
Annual accounts 202213,6 k €↓
2021
Annual accounts 2021571,8 k €↑
2021
Name changeORTHOPEDIE DE WINTERE
2020
Annual accounts 2020375,3 k €↑
2019
Annual accounts 201970,7 k €↑
2018
Annual accounts 201820,7 k €↑
2017
Annual accounts 20171,8 k €↓
2016
Annual accounts 201618,1 k €↑
2015
Annual accounts 20156 k €↓
2014
Annual accounts 201417,9 k €
18/10/2012
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Eqwal Stomacare

Overview

What does Eqwal Stomacare do?

Trend over 12 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline